Deviation of xenogeneic immune response and bystander suppression in rats fed porcine blood mononuclear cells

Transplant Immunology

Volumn 17, Issue 4, 2007, Pages 262-270

  Bridle, Byram W ^a   Wilkie, Bruce N ^a   Jevnikar, Anthony M ^b,c   Mallard, Bonnie A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Antibodies; Rat; Tolerance; Xenotransplantation

Indexed keywords

EGG WHITE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; LYSOZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; BYSTANDER EFFECT; CELLULAR IMMUNITY; CONTROLLED STUDY; GRAFT REJECTION; IMMUNE RESPONSE; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; XENOGRAFT; XENOTRANSPLANTATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, HETEROPHILE; ANTIGENS, HETEROPHILE; GRAFT SURVIVAL; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; LEUKOCYTES, MONONUCLEAR; RATS; RATS, INBRED STRAINS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 34247588094     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.01.010     Document Type: Article

References (61)

1. Cascalho M., and Platt J.L. The immunological barrier to xenotransplantation. Immunity 14 4 (2001) 437-446
2. Parker W., Saadi S., Lin S.S., Holzknecht Z.E., Bustos M., and Platt J.L. Transplantation of discordant xenografts: a challenge revisited. Immunol Today 17 8 (1996) 373-378
3. Xu X.-C., Naziruddin B., Sasaki H., Smith D.M., and Mohanakumar T. Allele-specific and peptide-dependent recognition of swine leukocyte antigen class I by human cytotoxic T-cell clones. Transplant 68 4 (1999) 473-479
4. Butler D., Wadman M., Lehrman S., and Schiermeier Q. Last chance to stop and think on risks of xenotransplants. Nature 391 6665 (1998) 320-324
5. Auchincloss Jr. H. Xenogeneic transplantation. A review. Transplant 46 1 (1988) 1-20
6. Bartholomew A.M., Powelson J., Sachs D.H., Bailin M., Boskovic S., Colvin R., et al. Tolerance in a concordant nonhuman primate model. Transplant 68 11 (1999) 1708-1716
7. Garside P., and Mowatt A.M. Oral tolerance. Semin Immunol 13 3 (2001) 177-185
8. Strobel S., and Mowatt A.M. Immune responses to dietary antigens: oral tolerance. Immunol Today 19 4 (1998) 173-181
9. Challacombe S.J., and Tomasi Jr. T.B. Systemic tolerance and secretory immunity after oral immunization. J Exp Med 152 6 (1980) 1459-1472
10. Richman L.K., Graeff A.S., Yarchoan R., and Strober W. Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in the murine Peyer's patch after protein feeding. J Immunol 126 6 (1981) 2079-2083
11. Weiner H.L., Friedman A., Miller A., Khoury S.J., Al-Sabbagh A., Santos L.M.B., et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 12 (1994) 809-837
12. Miller A., Lider O., and Weiner H.L. Antigen-driven bystander suppression following oral administration of antigens. J Exp Med 174 4 (1991) 791-798
13. Sayegh M.H., Khoury S.J., Hancock W.W., Weiner H.L., and Carpenter C.B. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc Natl Acad Sci 89 16 (1992) 7762-7766
14. Sayegh M.H., Zhang Z.J., Hancock W.W., Kwok C.A., Carpenter C.B., and Weiner H.L. Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen. Transplant 53 1 (1992) 163-166
15. Hancock W.W., Khoury S.J., Carpenter C.B., and Sayegh M.H. Differential effects of oral versus intrathymic administration of polymorphic major histocompatibility complex class II peptides on mononuclear and endothelial cell activation and cytokine expression during a delayed-type hypersensitivity response. Am J Pathol 144 6 (1994) 1149-1158
16. Zavazava N., Fändrich F., Zhu X., Freese A., Behrens D., and Yoo-Ott K.-A. Oral feeding of an immunodominant MHC donor-derived synthetic class I peptide prolongs graft survival of heterotopic cardiac allografts in a high-responder rat strain combination. J Leukoc Biol 67 6 (2000) 793-800
17. Sayegh M.H., Khoury S.J., Hancock W.W., Weiner H.L., and Carpenter C.B. Mechanisms of oral tolerance by MHC peptides. Ann NY Acad Sci (1996) 338-345
18. Ghobrial R.R., Hamashima T., Wang M.E., Wang M., Stepkowski S.M., and Khan B.D. Induction of transplantation tolerance by chimeric donor/recipient class I RT1.A molecules. Transplant 62 7 (1996) 1002-1010
19. Ma S.W., Zhao D.L., Yin Z.Q., Mukherjee R., Singh B., Qin H.Y., et al. Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat Med 3 7 (1997) 793-796
20. Artik S., Haarhuis K., Wu X., Begerow J., and Gleichmann E. Tolerance to nickel: oral nickel administration induces a high frequency of anergic T cells with persistent suppressor activity. J Immunol 167 12 (2001) 6794-6803
21. Ilan Y., Gotsman I., Pines M., Beinart R., Zeira M., Ohana M., et al. Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model. Blood 95 11 (2000) 3613-3619
22. Ishido N., Matsuoka J., Matsuno T., Nakagawa K., and Tanaka N. Induction of donor-specific hyporesponsiveness and prolongation of cardiac allograft survival by jejunal administration of donor splenocytes. Transplant 68 9 (1999) 1377-1382
23. Nagler A., Pines M., Abadi U., Pappo O., Zeira M., Rabbani E., et al. Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice. Hepatology 31 3 (2000) 641-648
24. Dettino A.L.A., Duarte A.J.S., and Sato M.N. Induction of oral tolerance and the effect of interleukin-4 on murine skin allograft rejection. Braz J Med Biol Res 37 3 (2004) 435-440
25. Nisco S., Vriens P., Hoyt G., Lyu S., Farfan F., Pouletty P., et al. Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A. J Immunol 152 8 (1994) 3786-3792
26. Buelow R., Veyron P., Clayberger C., Pouletty P., and Touraine J. Prolongation of skin allograft survival in mice following administration of allotrap. Transplant 59 4 (1995) 455-460
27. Hancock W., Sayegh M., Kwok C., and Weiner H. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft TH2 cell activation. Transplant 55 5 (1993) 1112-1118
28. Brandeis J., Sayegh M., Gallon L., and Blumberg R. Rat interstitial epithelial cells present major histocompatibility complex allopeptides to primed T cells. Gastroenterology 107 5 (1994) 1537-1542
29. In: Weiner H.L., and Mayer L.F. (Eds). Oral tolerance: mechanisms and applications (1996), New York Acad Of Sci, New York
30. Hartig C.V., Haller G.W., Sachs D.H., Kuhlenschmidt S., and Heeger P.S. Naturally developing memory T cell xenoreactivity to swine antigens in human peripheral blood lymphocytes. J Immunol 164 5 (2000) 27900-27906
31. Niimi M., Shirasugi N., Hamano K., Esato K., Matsumoto K., Ikeda Y., et al. Oral delivery of xenoantigen combined with non-depleting anti-CD4 monoclonal antibody induces significantly prolonged survival of concordant skin xenograft. Xenotransplantation 8 1 (2001) 75-79
32. Cooper D.K.C., Gollackner B., and Sachs D.H. Will the pig solve the transplantation backlog?. Annu Rev Med 53 (2002) 133-147
33. Butcher G.W., and Howard J.C. Genetic control of transplantation rejection. Transplant 34 4 (1982) 161-166
34. + T cells in low- and high-responder rat strains. J Immunol 143 9 (1989) 2828-2836
35. Hall B.M. Mechanisms of induction of tolerance to organ allografts. Crit Rev Immunol 20 4 (2000) 267-324
36. Bridle B.W., Wilkie B.N., Jevnikar A.M., and Mallard B.A. Rat genotype influences quantitative and qualitative aspects of xenogeneic immune response to porcine blood mononuclear cells. Xenotransplantation 13 4 (2006) 299-307
37. Bachmann M.F., and Kopf M. The role of B cells in acute and chronic infections. Curr Opin Immunol 11 3 (1999) 332-339
38. Hall B.M. Cells mediating allograft rejection. Transplant 51 6 (1991) 1141-1151 [Erratum in: Transplant 1991; 52(5); 936]
39. Huang J., Garmise R.J., Crowder T.M., Mar K., Hwang C.R., Hickey A.J., et al. A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats. Vaccine 23 6 (2004) 794-801
40. Gracie J.A., and Bradley J.A. Interleukin-12 induces interferon-gamma-dependent switching of IgG antibody subclass. Eur J Immunol 26 6 (1996) 1217-1221
41. Saoudi A., Bernard I., Hoedemaekers A., Cautain B., Martinez K., Druet P., et al. Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats. J Immunol 162 12 (1999) 7189-7197
42. Cêtre C., Pierrot C., Cocude C., Lafitte S., Capron A., Capron M., et al. Profiles of Th1 and Th2 cytokines after primary and secondary infection by Schistosoma mansoni in the semipermissive rat host. Infect Immun 67 6 (1999) 2713-2719
43. Oriol R., Ye Y., Koren E., and Cooper D.K.C. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplant 56 6 (1993) 1433-1442
44. Good A.H., Cooper D.K.C., Malcolm A.J., Ippolito R.M., Koren E., Neethling F.A., et al. Identification of carbohydrate structures which bind human anti-porcine antibodies: implications for discordant xenografting in man. Transplant Proc 24 2 (1992) 559-562
45. Sandrin M.S., Vaughan H.A., Dabkowski P.L., and McKenzie I.F.C. Anti-pig IgM antibodies in human serum react predominantly with Galα(1,3)Gal epitopes. Proc Natl Acad Sci U S A 90 23 (1993) 11391-11395
46. Lambrigts D., Sachs D.H., and Cooper D.K.C. Discordant organ xenotransplantation in primates - world experience and current status. Transplant 66 55 (1998) 547-561
47. Zaidi A., Schmoeckel M., Bhatti F., Waterworth P., Tolan M., Cozzi E., et al. Life-supporting pig-to-primate renal transplantation using genetically modified donors. Transplant 65 12 (1998) 1584-1590
48. Schmoeckel M., Bhatti F.N.K., Zaidi A., Cozzi E., Waterworth P.D., Tolan M.J., et al. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplant 65 12 (1998) 1570-1577 [Erratum in: Transplant 1998; 66(7); 943]
49. Phelps C.J., Koike C., Vaught T.D., Boone J., Wells K.D., Chen S.H., et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 299 5605 (2003) 411-414
50. Buhler L., Basker M., Alwayn I.P.J., Goepfert C., Kitamura H., Kawai T., et al. Coagulation and thrombotic disorders associated with pig organ transplantation in nonhuman primates. Transplant 70 9 (2000) 1323-1331
51. Shimizu A., Meehan S.M., Kozlowski T., Sablinski T., Ierino F.L., Cooper D.K., et al. Acute humoral xenograft rejection: destruction of the microvascular capillary endothelium in pig-to-nonhuman primate renal grafts. Lab Invest 80 6 (2000) 815-830
52. Robson S.C., Cooper D.K.C., and d'Apice A.J.F. Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 7 3 (2000) 166-176
53. Platt J.L., Lin S.S., and McGregor C.G.A. Acute vascular rejection. Xenotransplantation 5 3 (1998) 169-175
54. Lin Y., Vandeputte M., and Waer M. Accommodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts. J Immunol 160 1 (1998) 369-375
55. Lin S.S., Hanaway M.J., Gonzalez-Stawinski G.V., Lau C.L., Parker W., Davis R.D., et al. The role of anti-Galα1-3Gal antibodies in acute vascular rejection of xenotransplants and accommodation of xenografts. Transplant 70 12 (2000) 1667-1674
56. Platt J.L., Vercellotti G.M., Dalmasso A.P., Matas A.J., Bolman R.M., Najarian J.S., et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 11 12 (1990) 450-456
57. Miyatake T., Sato K., Takigami K., Koyamada N., Hancock W.W., Bazin H., et al. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection. J Immunol 160 8 (1998) 4114-4123
58. Segal B.M., and Shevach E.M. The straight talk on immune deviation. Clin Immunol Immunopathol 88 1 (1998) 1-3
59. Kobayashi K., Kaneda K., and Kasama T. Immunopathogenesis of delayed-type hypersensitivity. Microsc Res Tech 53 4 (2001) 241-245
60. Welsh R.M., and McNally J.M. Immune deficiency, immune silencing, and clonal exhaustion of T cell responses during viral infections. Curr Opin Microbiol 2 4 (1999) 382-387
61. Del Guidice G. Vaccination strategies. An overview. Vaccine 21 Suppl 2 (2003) S83